[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hr-her2--metastatic-breast-cancer-ovarian-cancer-fallopian-tube-cancer-primary-peritoneal-cancer-triple-negative-breast-cancer-male-breast-cancer\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hr-her2--metastatic-breast-cancer-ovarian-cancer-fallopian-tube-cancer-primary-peritoneal-cancer-triple-negative-breast-cancer-male-breast-cancer":7},{"pageToken":4,"total":5,"offset":5,"count":5,"results":6},null,0,[],"HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer"]